News & Updates

What are the risk factors for severe infections in hospitalized SLE patients?

19 Apr 2024

Among hospitalized patients with systemic lupus erythematosus (SLE), factors such as low immunoglobulin, anti-dsDNA antibody positivity, and cyclophosphamide use contribute to an increased risk of recurrent severe infections, according to a study.

What are the risk factors for severe infections in hospitalized SLE patients?

19 Apr 2024

MMF trumps azathioprine for remission in treatment-naive AIH

16 Apr 2024 by

Treatment with mycophenolate mofetil (MMF) in combination with prednisolone results in better biochemical remission rates at 24 weeks than the use of azathioprine plus prednisolone in patients with treatment-naïve autoimmune hepatitis (AIH), reports a study.

MMF trumps azathioprine for remission in treatment-naive AIH

16 Apr 2024

COVID rebound common, does not differ after VV116 vs nirmatrelvir–ritonavir treatment

15 Apr 2024 by

Many patients with mild-to-moderate COVID-19 experience a resurgence of the virus as well as symptoms after a standard 5-day course of treatment with either VV116 or nirmatrelvir–ritonavir, as shown in a study from China.

COVID rebound common, does not differ after VV116 vs nirmatrelvir–ritonavir treatment

15 Apr 2024

$Long-term TDF use ups fracture risk in older CHB patients$

Long-term TDF use ups fracture risk in older CHB patients

15 Apr 2024

Use of tenofovir disoproxil fumarate (TDF) for ≥24 months increases the risk of fracture in older patients with chronic hepatitis B (CHB), reports a study.

Long-term TDF use ups fracture risk in older CHB patients

15 Apr 2024

Probiotics may help in the fight against COVID-19

15 Apr 2024 by

Post-exposure prophylaxis with the probiotic Lacticaseibacillus rhamnosus GG (LGG) led to prolonged time to COVID-19 infection, reduced incidence of symptoms, and gut microbiome changes, but not overall incidence, a study suggests.

Probiotics may help in the fight against COVID-19

15 Apr 2024

2 drugs in 1 pill better than complex regimens for HIV

09 Apr 2024 by

The combination of bictegravir and lenacapavir, taken orally once daily, performed better than current complex treatment regimens in the phase II ARTISTRY-1 trial of people with HIV who are virologically suppressed.

2 drugs in 1 pill better than complex regimens for HIV

09 Apr 2024

Growing incidence of HPV-positive oropharyngeal cancer in HK

09 Apr 2024 by

A retrospective study by the Chinese University of Hong Kong (CUHK) reports a growing incidence of oropharyngeal cancer, with an increasing proportion of human papillomavirus (HPV)–positive cases in Hong Kong in recent years.

Growing incidence of HPV-positive oropharyngeal cancer in HK

09 Apr 2024

$TDF ups fracture risk in older patients with chronic hepatitis B$

TDF ups fracture risk in older patients with chronic hepatitis B

05 Apr 2024 by

Tenofovir disoproxil fumarate (TDF) is associated with a higher fracture risk vs entecavir (ETV) after 2 years of treatment in older patients with chronic hepatitis B (CHB), a territory-wide cohort study has shown.